Schedule 13G ownership disclosure

MATINAS BIOPHARMA HLDGS INC

Security class unavailable · CUSIP: 576810105

Event date: 2019-03-18

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
825,000
Percent of class
0.7000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001615774-19-004564
Form type
SC 13G
Filer
Matinas BioPharma Holdings, Inc.
CIK
CIK 1582554
Filed
Mar 26, 2019
Reporting period
Mar 18, 2019
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub